334 related articles for article (PubMed ID: 32197638)
1. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
Ishiuchi N; Nakashima A; Doi S; Yoshida K; Maeda S; Kanai R; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Stem Cell Res Ther; 2020 Mar; 11(1):130. PubMed ID: 32197638
[TBL] [Abstract][Full Text] [Related]
2. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis.
Ishiuchi N; Nakashima A; Doi S; Kanai R; Maeda S; Takahashi S; Nagao M; Masaki T
Stem Cell Res Ther; 2021 Aug; 12(1):472. PubMed ID: 34425892
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
Feng J; Yao W; Zhang Y; Xiang AP; Yuan D; Hei Z
Cell Physiol Biochem; 2018; 47(2):556-566. PubMed ID: 29794450
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis.
Kanai R; Nakashima A; Doi S; Kimura T; Yoshida K; Maeda S; Ishiuchi N; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Sci Rep; 2021 Jan; 11(1):850. PubMed ID: 33441701
[TBL] [Abstract][Full Text] [Related]
8. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X
Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215
[TBL] [Abstract][Full Text] [Related]
10. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
13. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
Yang J; Tang L; Zhang F; Yang T; Lu T; Sun K; Sun N; Ren J; Yan M
Stem Cell Res Ther; 2021 Nov; 12(1):584. PubMed ID: 34809715
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
16. 14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.
Tian H; Lu Y; Shah SP; Wang Q; Hong S
Stem Cells Dev; 2012 May; 21(7):1187-99. PubMed ID: 21846180
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction.
Kurawaki S; Nakashima A; Ishiuchi N; Kanai R; Maeda S; Sasaki K; Masaki T
Sci Rep; 2024 May; 14(1):10251. PubMed ID: 38704512
[TBL] [Abstract][Full Text] [Related]
18. Adipose-Derived Mesenchymal Stromal Cells Under Hypoxia: Changes in Extracellular Vesicles Secretion and Improvement of Renal Recovery after Ischemic Injury.
Collino F; Lopes JA; Corrêa S; Abdelhay E; Takiya CM; Wendt CHC; de Miranda KR; Vieyra A; Lindoso RS
Cell Physiol Biochem; 2019; 52(6):1463-1483. PubMed ID: 31099507
[TBL] [Abstract][Full Text] [Related]
19. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects.
Kadono M; Nakashima A; Ishiuchi N; Sasaki K; Miura Y; Maeda S; Fujita A; Sasaki A; Nagamatsu S; Masaki T
Stem Cell Res Ther; 2023 Nov; 14(1):337. PubMed ID: 37993965
[TBL] [Abstract][Full Text] [Related]
20. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
